Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Phone717-761-2633
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$21.53 billion
Profitability
Miscellaneous
Employees59,000
Next Earnings Date4/11/2019 (Estimated)
OptionableOptionable
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
How were Rite Aid's earnings last quarter?
Rite Aid Co. (NYSE:RAD) posted its quarterly earnings data on Wednesday, December, 19th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.01) by $0.02. The firm had revenue of $5.45 billion for the quarter, compared to the consensus estimate of $5.45 billion. Rite Aid had a net margin of 2.85% and a negative return on equity of 0.94%. The business's revenue for the quarter was up 1.8% on a year-over-year basis. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What guidance has Rite Aid issued on next quarter's earnings?
Rite Aid updated its FY19 earnings guidance on Wednesday, December, 19th. The company provided EPS guidance of ($0.03)-($0.01) for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.00. The company issued revenue guidance of $21.8-$21.95 billion, compared to the consensus revenue estimate of $21.80 billion.Rite Aid also updated its FY 2019 guidance to $-0.03--0.01 EPS.
What price target have analysts set for RAD?
5 Wall Street analysts have issued 12 month target prices for Rite Aid's stock. Their predictions range from $1.00 to $6.00. On average, they anticipate Rite Aid's stock price to reach $2.20 in the next year. This suggests a possible upside of 193.3% from the stock's current price. View Analyst Price Targets for Rite Aid.
What is the consensus analysts' recommendation for Rite Aid?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Rite Aid.
Has Rite Aid been receiving favorable news coverage?
News articles about RAD stock have been trending somewhat positive on Thursday, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Rite Aid earned a daily sentiment score of 1.7 on InfoTrie's scale. They also gave media stories about the company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the next few days.
Are investors shorting Rite Aid?
Rite Aid saw a increase in short interest during the month of January. As of January 31st, there was short interest totalling 111,399,642 shares, an increase of 4.4% from the January 15th total of 106,738,612 shares. Based on an average daily volume of 14,599,553 shares, the days-to-cover ratio is presently 7.6 days. Approximately 10.6% of the shares of the stock are short sold. View Rite Aid's Current Options Chain.
Who are some of Rite Aid's key competitors?
What other stocks do shareholders of Rite Aid own?
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, CEO & Director (Age 56)
- Mr. Kermit Ray Crawford, Pres & COO (Age 60)
- Mr. Darren Wayne Karst, Sr. EVP, CFO & Chief Admin. Officer (Age 59)
- Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy (Age 49)
- Mr. Bryan B. Everett, Chief Operating Officer of Rite Aid Stores (Age 46)
Who are Rite Aid's major shareholders?
Rite Aid's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.07%), Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp (2.26%), Northern Trust Corp (1.15%), Geode Capital Management LLC (1.03%), Dimensional Fund Advisors LP (0.45%) and Bank of New York Mellon Corp (0.43%). View Institutional Ownership Trends for Rite Aid.
Which institutional investors are selling Rite Aid stock?
RAD stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Private Management Group Inc., Dimensional Fund Advisors LP, Bank of New York Mellon Corp, Gabelli Funds LLC, Two Sigma Advisers LP, Stone Ridge Asset Management LLC and Creative Planning. View Insider Buying and Selling for Rite Aid.
Which institutional investors are buying Rite Aid stock?
RAD stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Geode Capital Management LLC, SG Americas Securities LLC, Hsbc Holdings PLC, Cumberland Advisors Inc., Rhumbline Advisers and Numen Capital LLP. View Insider Buying and Selling for Rite Aid.
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $0.75.
How big of a company is Rite Aid?
Rite Aid has a market capitalization of $809.93 million and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 59,000 workers across the globe.
What is Rite Aid's official website?
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17011. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (NYSE RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
